Singapore / A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy,…
Singapore
APAC / Liquid Biopsies & The Future of Cancer Diagnostics
In 2020, the FDA granted its first approval to a comprehensive liquid biopsy, potentially representing a paradigm shift towards using liquid biopsies upfront as an easier, safer, faster, and more…
Singapore / Building a Globally Competitive Innovation Ecosystem
Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest…
Pharma Faces / Marine Queniart-Stojanovic, Sanofi Thailand, Malaysia & Singapore
Industry veteran Marine Queniart-Stojanovic, a self-described “global citizen with a French passport,”…
In Conversation
Erika Pagani – Country Manager, Pfizer Singapore
Erika Pagani, country manager for Pfizer Singapore, shares her journey with the company from Brazil to New York, Peru, Ecuador, and finally Singapore. She discusses why the island city-state is well-positioned as a launchpad for Pfizer’s innovation and the “laboratory” for emerging Asia, and how the company is working to win the digital race, changing its go-to-market model. Singapore…
Singapore / Pharma Industry Snapshot 2020
Singapore is home to a wide range of biopharmaceutical company headquarters, many of them regional bases, and…
Pharma Faces / Marine Queniart-Stojanovic, Sanofi Thailand, Malaysia & Singapore
Industry veteran Marine Queniart-Stojanovic, a self-described “global citizen with a French passport,”…
Biosimilars & Biologics: Singapore
A brief overview of the situation regarding biosimilars & biologics in Singaporean Pharma. Prepared in…
Singapore: The Biopolis of Asia
When Singapore became independent in 1965, the smart money was not on this small South East Asian island with…
Global / PharmaBoardroom’s Top 10 Most Read Interviews of 2021 (So Far)
PharmaBoardroom has spread its wings far and wide in 2021 (albeit digitally!), from well covered markets such as…
Asia-Pacific / HSA: A Regulatory Gold Standard for the Region
As the most important pharma hub in its region, and one of the most important globally, many companies look to…
APAC / Singapore Pharma Exports Rise as Global API Demand Surges
The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global…
APAC / The Challenges of Regulatory Convergence in Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue,…
Pharma Faces / Marine Queniart-Stojanovic, Sanofi Thailand, Malaysia & Singapore
Industry veteran Marine Queniart-Stojanovic, a self-described “global citizen with a French passport,”…
Singapore’s Recipe for Success
Singapore, though conscious of its limitations, has been able to leverage its key assets of location,…
Southeast Asia / Singapore Pharma Production Surge; Indonesian Self-Sufficiency; Philippines Sputnik Vaccine Manufacturing
The latest from Southeast Asian pharma, including soaring output in Singapore, tax breaks for research in…
Singapore / A Myriad of Biotech Financing Strategies
Since 2000, when Singapore first positioned biomedical research as the fourth pillar of the country’s economy,…
Singaporean Logistics: Taking Pharma to New Heights
Singapore’s location at the heart of the APAC region, expertise in logistics and cold chain management, and…
Singapore / Building a Globally Competitive Innovation Ecosystem
Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest…
APAC / Diagnostics in the Post-COVID Era
COVID-19 has pushed diagnostics to the forefront of healthcare conversations across the world. Here, three leading…